FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3190497877> ?p ?o ?g. }

• W3190497877 endingPage "43" @default.
• W3190497877 startingPage "34" @default.
• W3190497877 abstract "Allogeneic hematopoietic stem-cell transplantation (allo-HSCT) remains the best curative option for high-risk myelodysplastic syndrome . We retrospectively compared patient outcomes after allo-HSCT according to the intensity of the conditioning regimen.Three conditioning regimens were compared in 427 patients allografted for high-risk myelodysplastic syndrome: reduced-intensity conditioning (RIC), fludarabine (150-160 mg/m2) and busulfan (6.4 mg/kg); sequential FLAMSA-RIC, fludarabine, amsacrine, and aracytine followed by RIC; and myeloablative with reduced toxicity (RTC), fludarabine and busulfan (9.6 mg/kg or 12.8 mg/kg).The patients in the 3 conditioning groups were different in regards to the number of treatment lines (P< .001), percentage of blasts in bone marrow (P< .001), and disease status at transplantation (P< .001). No significant differences in outcomes (overall survival, progression-free survival, nonrelapse mortality, relapse incidence, and graft versus host disease relapse-free survival) were observed between the 3 groups. Using propensity score analysis to overcome baseline imbalances, we compared 70 patients receiving FLAMSA-RIC to 260 patients receiving RIC, and compared 83 patients receiving RTC to 252 patients receiving RIC. The only factor influencing overall and progression-free survival was cytogenetic risk at transplantation. After the covariate adjustment using propensity score to reduce baseline imbalances, the only factor influencing overall and progression-free survival was still cytogenetic risk at transplantation.Overall survival appears to be similar with the 3 conditioning regimens. The only factor influencing survival is cytogenetic risk at transplantation, suggesting that new promising drugs in the conditioning and/or early interventions after transplantation are needed to improve outcomes in these patients." @default.
• W3190497877 created "2021-08-16" @default.
• W3190497877 creator A5008215689 @default.
• W3190497877 creator A5010183839 @default.
• W3190497877 creator A5025925500 @default.
• W3190497877 creator A5027624956 @default.
• W3190497877 creator A5029106095 @default.
• W3190497877 creator A5041241154 @default.
• W3190497877 creator A5042424335 @default.
• W3190497877 creator A5043343452 @default.
• W3190497877 creator A5043566257 @default.
• W3190497877 creator A5046038563 @default.
• W3190497877 creator A5051712823 @default.
• W3190497877 creator A5052502171 @default.
• W3190497877 creator A5059403965 @default.
• W3190497877 creator A5063206095 @default.
• W3190497877 creator A5072757261 @default.
• W3190497877 creator A5084578107 @default.
• W3190497877 creator A5086317399 @default.
• W3190497877 creator A5089360800 @default.
• W3190497877 date "2022-01-01" @default.
• W3190497877 modified "2023-10-18" @default.
• W3190497877 title "On Behalf of the SFGM-TC: Retrospective Comparison of Reduced and Higher Intensity Conditioning for High-Risk Myelodysplastic Syndrome Treated With Allogeneic Stem-Cell Transplantation" @default.
• W3190497877 cites W1761464837 @default.
• W3190497877 cites W187238933 @default.
• W3190497877 cites W1971100781 @default.
• W3190497877 cites W1978195896 @default.
• W3190497877 cites W1982068584 @default.
• W3190497877 cites W1983344261 @default.
• W3190497877 cites W1987350756 @default.
• W3190497877 cites W1991125854 @default.
• W3190497877 cites W1992090010 @default.
• W3190497877 cites W1997059306 @default.
• W3190497877 cites W2001839862 @default.
• W3190497877 cites W2005087893 @default.
• W3190497877 cites W2019111335 @default.
• W3190497877 cites W2030452018 @default.
• W3190497877 cites W2034504872 @default.
• W3190497877 cites W2044357856 @default.
• W3190497877 cites W2048365016 @default.
• W3190497877 cites W2058256886 @default.
• W3190497877 cites W2069566335 @default.
• W3190497877 cites W2078790776 @default.
• W3190497877 cites W2097401497 @default.
• W3190497877 cites W2098989605 @default.
• W3190497877 cites W2103628120 @default.
• W3190497877 cites W2122587491 @default.
• W3190497877 cites W2131639268 @default.
• W3190497877 cites W2147773887 @default.
• W3190497877 cites W2164426492 @default.
• W3190497877 cites W2209448786 @default.
• W3190497877 cites W2326726820 @default.
• W3190497877 cites W2510134076 @default.
• W3190497877 cites W2575545223 @default.
• W3190497877 cites W2587066646 @default.
• W3190497877 cites W2589411765 @default.
• W3190497877 cites W2590030902 @default.
• W3190497877 cites W2610625257 @default.
• W3190497877 cites W2610835498 @default.
• W3190497877 cites W2618073389 @default.
• W3190497877 cites W2978735030 @default.
• W3190497877 cites W3010001025 @default.
• W3190497877 cites W3044024827 @default.
• W3190497877 cites W3101738346 @default.
• W3190497877 cites W347010909 @default.
• W3190497877 doi "https://doi.org/10.1016/j.clml.2021.07.027" @default.
• W3190497877 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34456160" @default.
• W3190497877 hasPublicationYear "2022" @default.
• W3190497877 type Work @default.
• W3190497877 sameAs 3190497877 @default.
• W3190497877 citedByCount "3" @default.
• W3190497877 countsByYear W31904978772022 @default.
• W3190497877 countsByYear W31904978772023 @default.
• W3190497877 crossrefType "journal-article" @default.
• W3190497877 hasAuthorship W3190497877A5008215689 @default.
• W3190497877 hasAuthorship W3190497877A5010183839 @default.
• W3190497877 hasAuthorship W3190497877A5025925500 @default.
• W3190497877 hasAuthorship W3190497877A5027624956 @default.
• W3190497877 hasAuthorship W3190497877A5029106095 @default.
• W3190497877 hasAuthorship W3190497877A5041241154 @default.
• W3190497877 hasAuthorship W3190497877A5042424335 @default.
• W3190497877 hasAuthorship W3190497877A5043343452 @default.
• W3190497877 hasAuthorship W3190497877A5043566257 @default.
• W3190497877 hasAuthorship W3190497877A5046038563 @default.
• W3190497877 hasAuthorship W3190497877A5051712823 @default.
• W3190497877 hasAuthorship W3190497877A5052502171 @default.
• W3190497877 hasAuthorship W3190497877A5059403965 @default.
• W3190497877 hasAuthorship W3190497877A5063206095 @default.
• W3190497877 hasAuthorship W3190497877A5072757261 @default.
• W3190497877 hasAuthorship W3190497877A5084578107 @default.
• W3190497877 hasAuthorship W3190497877A5086317399 @default.
• W3190497877 hasAuthorship W3190497877A5089360800 @default.
• W3190497877 hasBestOaLocation W31904978771 @default.
• W3190497877 hasConcept C126322002 @default.
• W3190497877 hasConcept C141071460 @default.
• W3190497877 hasConcept C143998085 @default.
• W3190497877 hasConcept C2776694085 @default.
• W3190497877 hasConcept C2776755627 @default.

• next